The ROMA (Risk of Ovarian Malignancy) Test is a specialized screening test that combines CA125 and ROMA scores to help assess the risk of ovarian malignancy in premenopausal and postmenopausal women. It supports the evaluation of ovarian masses and assists in clinical risk assessment.
CANCER MARKER [3]
CA125
ROMA – PREMENOPAUSAL
ROMA – POSTMENOPAUSAL
HEMATOLOGY [1]
HUMAN EPIDIDYMIS PROTEIN 4
Parameters
32 Parameters
Fasting
8–10 hours required
Report time
24–48 hours
Sample type
Blood & Urine
Age group
All age groups
Home collection
Available
How the Process Works
Enter your pincode and check service availability.
Select your preferred appointment date and time slot.
A trained Thyrocare technician will visit your address for sample collection.
After booking confirmation, you will receive a payment link for secure online payment.
Your samples will be processed in NABL accredited laboratories.
Digital reports will be delivered to your registered email address within 24–48 hours.